Relative levels of cytoprotection produced by analogs of choline and the role of α7-nicotinic acetylcholine receptors

Synapse

Volumn 47, Issue 4, 2003, Pages 262-269

  Jonnala, Ramamohana R ^a   Graham III, John H ^b   Terry Jr , Alvin V ^a,c   Beach, J Warren ^c   Young, Jennifer A ^c   Buccafusco, Jerry J ^a,d  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b King College   (United States)

^c UNIVERSITY OF GEORGIA   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Cell culture; Cholinergic receptors; Growth factors; Neuroprotection; Upregulation

Indexed keywords

ACETYLCHOLINE; ALPHA BUNGAROTOXIN; CHOLINE DERIVATIVE; GROWTH FACTOR; METHYLLYCACONITINE; NEUROTRANSMITTER; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR BLOCKING AGENT; PYRROLIDINE DERIVATIVE; RECEPTOR SUBTYPE;

AMINO ACID SUBSTITUTION; ARTICLE; BINDING SITE; CELL CULTURE; CELL PROTECTION; CELL SURFACE; CENTRAL NERVOUS SYSTEM; CHEMICAL STRUCTURE; CHOLINERGIC TRANSMISSION; CONTROLLED STUDY; HUMAN; HUMAN CELL; MOLECULAR MODEL; NEUROPROTECTION; PRIORITY JOURNAL; PROTEIN STRUCTURE; RECEPTOR UPREGULATION;

ANIMALS; BINDING, COMPETITIVE; BUNGAROTOXINS; CELL MEMBRANE; CHOLINE; CYTOPROTECTION; GROWTH SUBSTANCES; NEURONS; NEUROPROTECTIVE AGENTS; NICOTINIC ANTAGONISTS; PC12 CELLS; RATS; RECEPTORS, NICOTINIC;

EID: 0037444897     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/syn.10176     Document Type: Article

References (47)

1. Akaike A, Tamura Y, Yokota T, Shimohama S, Kimura J. 1994. Nicotine-induced protection of cultured cortical neurons against N-methyl-D-aspartate receptor-mediated glutamate cytotoxicity. Brain Res 644:181-187.
2. Alkondon M, Pereira EFR, Cortes WS, Maelicke A, Albuquerque EX. 1997. Choline is a selective agonist of α7 nicotinic acetylcholine receptors in rat brain neurons. Eur J Neurosci 9:2734-2742.
3. Alkondon M, Braga, MFM, Pereira EFR, Maelicke A, Albuquerque EX. 2000. α7 Nicotinic acetylcholine receptors and modulation of GABAergic synaptic transmission in the hippocampus. Eur J Pharmacol 393:59-67.
4. Arneric SP, Sullivan JP, Decker MW, Brioni JD, Bannon AW, Briggs CA, Donnelly-Roberts D, Radek RJ, Marsh KC, Kyncl J, Williams M, Buccafusco JJ. 1995. Potential treatment of Alzheimer disease using cholinergic channel activators (ChCAs) with cognitive enhancement, anxiolytic-like, and cytoprotective properties. Alzheimer Dis Assoc Dis 9:50-61.
5. Aronstam RS, Buccafusco JJ. 1982. Cholinergic actions of false neurotransmitters: acetyldiethylcholine. Neurosci Lett 28:51-56.
6. Aronstam RS, Marshall DC, Buccafusco JJ. 1988. Cholinergic false transmitters: physiological and biochemical actions in central and peripheral systems. Neuropharmacology 27:217-225.
7. Barker LA, Mittag TW. 1975. Comparative studies of substrates and inhibitors of choline transport and choline acetyltransferase. J Pharmacol Exp Ther 192:86-94.
8. Benishin CG, Carroll PT.1981. Acetylation of choline and homocholine by membrane-bound choline-O-acetyltransferase in mouse forebrain nerve endings. J Neurochem 36:732-740.
9. Bennett Jr JP. 1978. Methods in binding studies. In: Yamamura HI, editor. Neurotransmitter receptor binding. New York: Raven Press. p 57-90.
10. Boksa P, Collier B. 1980. N-Ethyl analogues of choline as precursors to cholinergic false transmitters. J Neurochem 35:1099-1104.
11. Bontempi B, Whelan KT, Risbrough VB, Joppa MA, Reid RT, Buccafusco JJ, Waller JL, Lloyd GK, Menzaghi F. 2001. SIB-1553A ((±)2-[2-(4-hydroxyphenyl) thioethyl]-1-methypyrolidine), a novel cholinergic ion channel agonist with cognitive-enhancing properties. III. Effects on memory performance in aged rodents and non-human primates. J Pharmacol Exp Ther (in press).
12. Briggs CA, Anderson DJ, Brioni JD, Buccafusco JJ, Buckley MJ, Campbell JE, Decker MW, Donnelly-Roberts D, Elliott RL, Holladay MW, Hui Y-H, Jackson WJ, Kim DJB, Marsh KC, O'Neill A, Prendergast MA, Ryther KB, Sullivan JP, Arneric SP. 1997. Functional characterization of the novel neuronal nicotinic acetylcholine receptor ligand GTS-21. In vitro and in vivo. Pharmacol Biochem Behav 57:231-241.
13. Buccafusco JJ, Aronstam RS. 1981. Cholinergic actions of false neurotransmitters: acetylpyrrolidine choline. Neurosci Lett 23:319-324.
14. Buccafusco JJ, Aronstam RS. 1988. Precursors of cholinergic false transmitters: central effects on blood pressure and direct interactions with cholinergic receptors. Neuropharmacology 27:227-233.
15. Buccafusco JJ, Prendergast M, Terry Jr AV, Jackson WJ. 1996. Cognitive effects of nicotinic cholinergic agonists in non-human primates. Drug Dev Res 38:196-203.
16. Burton MD, Nouri M, Kazemi H. 1995. Acetylcholine and central respiratory control: perturbations of acetylcholine synthesis in the isolated brainstem of the neonatal rat. Brain Res 670:39-47.
17. Gebber GL, Volle RL. 1965. Ganglionic stimulating properties of aliphatic esters of choline and thiocholine. J Pharmacol Exp Ther 150:67-74.
18. Hong SJ, Rohde BH, Chiou GC. 1995. Use of C1300 neuroblastoma cells to evaluate the protective value of hexamethonium, trimethaphan, hemicholinium, and triethylcholine against diisopropyl phosphorofluoridate toxicity. J Pharm Sci 84:65-70.
19. Jenden DJ, Russell RW, Booth RA, Lauretz SD, Knusel BJ, Roch M, Rice KM, George R, Waite JJ. 1987. A model hypocholinergic syndrome produced by a false choline analog, N-aminodeanol. J Neural Transm Suppl 24:325-329.
20. Jenden DJ, Russell RW, Booth RA, Knusel BJ, Lauretz SD, Rice KM, Roch M. 1989. Effects of chronic in vivo replacement of choline with a false cholinergic precursor. EXS 57:229-235.
21. Jonnala RR, Buccafusco JJ. 1998. Nicotine increases the expression of TrkA receptors on differentiated PC12 cells. Soc Neurosci Abst 24:1340.
22. Jonnala RR, Buccafusco JJ. 2001. Relationship between cell surface α7 nicotinic receptor expression and neuroprotection. J Neurosci Res 66 (in press).
23. Kihara T, Shimohama S, Sawada H, Kimura J, Kume T, Kochiyama H, Maeda T, Akaike A. 1997. Nicotine receptor stimulation protects neurons against β-amyloid toxicity. Ann Neurol 42:159-163.
24. Kilbinger H, Wagner A, Zerban R. 1976. Some pharmacological properties of the false cholinergic transmitter acetylpyrrolidinecholine and its precursor pyrrolidinecholine. Naunyn Schmied Arch Pharmacol 295:81-87.
25. Krnjević K, Reinhardt W. 1979. Choline excites cortical neurons. Science 206:1321-1322.
26. Large WA, Rang HP. 1978. Factors affecting the rate of incorporation of a false transmitter into mammalian motor nerve terminals. J Physiol 285:1-24.
27. Lin Nan-Horng, Gunn DE, Ryther KB, Garvey DS, Donnelly-Roberts DL, Decker MW, Brioni JD, Buckley MJ, Rodrigues AD, Marsh KG, Anderson DJ, Buccafusco JJ, Prendergast MA, Sullivan JP, Williams M, Arneric SP, Holladay MW. 1997. Structure-activity studies on 2-methyl-3-(2(S)-pyrrolidinylmethoxy)pyridine (ABT-089): an orally bioavailable 3-pyridyl ether nicotinic acetylcholine receptor ligand with cognitive -enhancing properties. J Med Chem 40:385-390.
28. Marin P, Maus M, Desagher S, Glowinski J, Premont J. 1994. Nicotine protects cultured striatal neurons against N-methyl-D-aspartate receptor-mediated toxicity. Neuroreport 5:1977-1980.
29. Matthews RT, Chiou CY. 1979. Effects of diethylcholine in two animal models of Parkinsonism tremors. Eur J Pharmacol 56:159-165.
30. Meyer EM, Barrnett RJ, Cooper JR. 1998. Neurochemical characterization of an antimony-choline analog in rat cortical synaptosomes. J Neurochem 39:321-326.
31. Mike A, Castro NG, Albuquerque EX. 2000. Choline and acetylcholine have similar kinetic properties of activation and desensitization of the α7 nicotinic receptors in rat hippocampal neurons. Brain Res 882:155-168.
32. Mosmann T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cyttotoxicity assays. J Immunol Methods 65:55-58.
33. Naves LA, Balezina OP, Van der Kloot W. 1996. Monoethylcholine as a false transmitter precursor at the frog and mouse neuromuscular junctions. Brain Res 730:58-66.
34. Newton MW, Jenden DJ. 1985. Metabolism and subcellular distribution of N-amino-N,N-dimethylaminoethanol (N-aminodeanol) in rat striatal synaptosomes. J Pharmacol Exp Ther 235:135-146.
35. Owman C, Fuxe K, Jason AM, Kahrstrom J. 1989. Studies of protective actions of nicotine on neuronal and vascular functions in rats: comparison between sympathetic noradrenergic and mesostriatal dopaminergic fiber system, and the effect of a dopamine agonist. Prog Brain Res 79:267-276.
36. Papke RL, Bencherif P, Lippiello P. 1996. An evaluation of nicotinic acetylcholine receptor activation by quaternary nitrogen compounds indicates that choline is selective for the alpha 7 subtype. Neurosci Lett 213:201-204.
37. Papke RL, Meyer E, Nutter T, Uteshev VV. 2000. α7 Receptor-selective agonists and models of α7 receptor activation. Eur J Pharmacol 393:179-195.
38. Patterson TA, Terry Jr AV, Kosh JW. 1989. Prevention of physostigmine-, DFP-, and diazinon-induced acute toxicity by monoethylcholine and N-aminodeanol. Br J Pharmacol 97:451-460.
39. Redies C, Diksic M, Collier B, Gjedde A, Thompson CJ, Gauthier S, Feindel WH. 1988. Influx of a choline analog to dog brain measured by positron emission tomography. Synapse 2:406-411.
40. Strahlendorf JC, Acosta S, Miles R, Strahlendorf HK. 2001. Choline blocks AMPA-induced dark cell degeneration of purkinje neurons: potential role of the α7 nicotinic receptor. Brain Res 901:71-78.
41. Tees RD, Mohammadi E. 1999. The effects of neonatal choline dietary supplementation on adult spatial and configural learning and memory in rats. Dev Psychobiol 35:226-240.
42. Terry Jr AV, Clarke MSF. 1994. Nicotine stimulation of nerve growth factor receptor expression. Life Sci 55:91-98
43. Terry Jr AV, Silks LA, Dunlap RB, Odom JD, Kosh JW. 1993. Further biological activities of the novel choline analogs selenonium choline and acetylselenonium choline. J Pharmacol Exp Ther 266:593-601.
44. Thomas JD, La Fiette MH, Quinn VRE, Riley EP. 2000. Neonatal choline supplementation ameliorates the effects of prenatal alcohol exposure on a discrimination learning task in rats. Neurotoxicol Teratol 22:703-711.
45. Von Schwarzenfeld I, Wittaker VP. 1977. The pharmacological properties of the cholinergic false transmitter, N-2-acetyoxyethyl-N-methylpyrrolidinium, and its precursor, N-2-hydroxyethyl-N-methylpyrrolidinium. Br J Pharmacol 59:69-74.
46. Zamani MR, Allen YS, Owen GP, Gray JA. 1997. Nicotine modulates the neurotoxic effect of β-amyloid protein (25-35) in hippocampal cultures. Neuroreport 8:513-517.
47. Zwart R, Vijverberg HPM. 2000. Potentiation and inhibition of neuronal α4B4 nicotinic acetylcholine receptors by choline. Eur J Pharmacol 393:209-214.